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Individual and Center-Level Factors Affecting
Mortality Among Extremely Low Birth Weight Infants
WHAT’S KNOWN ON THIS SUBJECT: Significant variation in the
mortality of preterm infants has been observed among NICUs.
Factors explaining this variation have been difficult to identify.
WHAT THIS STUDY ADDS: Sizable center differences in mortality
exist, even among similarly sized NICUs in academic centers.
Patient characteristics and center treatment rates explain some
of the center effect, especially for the youngest infants, but
a significant portion of these differences remains unexplained.
abstract
OBJECTIVE: To examine factors affecting center differences in mor-
tality for extremely low birth weight (ELBW) infants.
METHODS: We analyzed data for 5418 ELBW infants born at 16 Neonatal
Research Network centers during 2006–2009. The primary outcomes
of early mortality (#12 hours after birth) and in-hospital mortality
were assessed by using multilevel hierarchical models. Models were
developed to investigate associations of center rates of selected
interventions with mortality while adjusting for patient-level risk
factors. These analyses were performed for all gestational ages
(GAs) and separately for GAs ,25 weeks and $25 weeks.
RESULTS: Early and in-hospital mortality rates among centers were 5%
to 36% and 11% to 53% for all GAs, 13% to 73% and 28% to 90% for GAs
,25 weeks, and 1% to 11% and 7% to 26% for GAs $25 weeks,
respectively. Center intervention rates significantly predicted both
early and in-hospital mortality for infants ,25 weeks. For infants
$25 weeks, intervention rates did not predict mortality. The
variance in mortality among centers was significant for all GAs and
outcomes. Center use of interventions and patient risk factors
explained some but not all of the center variation in mortality rates.
CONCLUSIONS: Center intervention rates explain a portion of the cen-
ter variation in mortality, especially for infants born at,25 weeks’ GA.
This finding suggests that deaths may be prevented by standardizing
care for very early GA infants. However, differences in patient char-
acteristics and center intervention rates do not account for all of the
observed variability in mortality; and for infants with GA $25 weeks
these differences account for only a small part of the variation in
mortality. Pediatrics 2013;132:e175–e184
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Both patient factors (eg, gestational age
[GA]) and preventive or therapeutic
interventions (eg, antenatal cortico-
steroids) are known to affect the mor-
tality risk of very preterm infants.1 The
hospital in which care is provided also
affects mortality risk. Variability in mor-
tality rate by center has been observed in
several populations and networks.2–7
Two factors may contribute to these
center differences: (1) the inherent risk
of the patient population served by
a center and (2) the patient care de-
livered at the center. Existing models to
predict neonatal mortality at birth are
based on individual patient character-
istics surrounding birth.1,8–11 These mod-
els are useful in providing outcome
benchmarks and have been modified as
clinical care has improved. They do not,
however, adequately address the center
effect on outcome. Variation in the pa-
tient populations accounts for some but
not all of the differences in mortality
among centers.12,13 Examining the effect
of center on the mortality of extremely
low birthweight (ELBW;#1000 g) infants
may yield insights into ways to improve
neonatal care.
The Eunice Kennedy Shriver National
Institute of Child Health and Human
Development Neonatal Research Net-
work (NRN), a consortium of university-
affiliated NICUs, has maintained a data
registry of extremely premature infants
using standard data collection and
follow-up assessment methods since
1986. This data set allows examination
of the variation in neonatal practice and
outcomes among academic medical
centers. It provides an opportunity to
examine possible explanations for the
center effect on mortality while con-
trolling for infant and maternal char-
acteristics. In this study, we estimated
the variability of ELBW mortality among
NRN centers. We assessed the effect of
the rates at which centers use certain
interventions on this variability in mor-
tality, while adjusting for the effects of
patient risk factors known to influence
mortality.
METHODS
Eligible infants fromall NRN centerswere
identified, and patient risk factors and
center intervention rates were extracted
from records of neonatal and maternal
characteristics and interventions avail-
able in the NRN registry. These variables
were used to build models designed to
predict mortality outcomes. Early mor-
tality (#12 hours) and in-hospital mor-
tality were analyzed separately, first for
all infants and then for 2 subgroups of
infants, those with GA ,25 weeks and
those with GA$25 weeks.
Data Source
Infants born at NRN centers in 2006–
2009 with birth weight of 401 to 1000 g
and GA of 22 (0/7) through 28 (6/7)
weeks were included. Infants with
syndromes or major malformations
were excluded. The final data set con-
sisted of 5418 infants from 16 centers.
NRN membership did not change dur-
ing the period of study, 2006–2009.
The NRN ELBW patient registry was
approved by the institutional review
boardateachparticipatingsite. Trained
researchpersonnel collectedmaternal,
pregnancy, delivery, and infant data as
well as morbidity and intervention data
from birth until hospital discharge,
death, or 120 days of age if still hospi-
talized. Hospital death after 120 days or
survival to discharge was obtained for
infants who were hospitalized for lon-
ger periods. Definitions for maternal
and infant characteristics and inter-
ventions were predetermined and de-
scribed in the manual of operations. GA
was determined as the best obstetric
estimate on the basis of the mother’s
last menstrual period and fetal ultra-
sonography. Patient risk factors and
interventions were obtained from in-
dividual patient records. Center in-
tervention rates were calculated from
the patient data within a given center.
Outcomes
The 2 main outcomes examined in this
study were mortality in the first 12
hours after birth (early mortality) and
mortality before discharge (in-hospital
mortality). These outcomes were not
mutually exclusive, because in-hospital
mortality included those infants who
died early. Deaths that occurred in the
delivery room were included in these
mortality outcomes. These outcomes
were additionally examined in 2 sub-
groups of patients, those with GA ,25
weeks and those with GA $25 weeks.
The rationale behind testing in these
subgroups was that centers or in-
dividual physicians within centers may
have different policies regarding the
resuscitation of infants born at ,25
weeks. We assumed that infants born
at$25 weeks’ GA were likely to receive
aggressive obstetric and neonatal
care, whereas infants born before 25
weeks might have had less aggressive
care before and after birth.14
Patient Risk Factors
Patient risk factors used in this study
included mother’s educational level
(less than versus high school diploma
or higher), private health insurance
coverage, prenatal care utilization,
gender of the infant, race, ethnicity,
birth weight, gestational age, 5-minute
Apgar score (,5 vs $5), and multiple
birth (versus single birth). Individual
birth weights and gestational ages




that may be related to mortality were
included in the analysis. These variables
were as follows: provision of antenatal
corticosteroids, mode of delivery, sup-
port given to the infant at delivery
(continuous positive airway pressure
[CPAP], tracheal intubation, epineph-
rine), NICU admission, prophylactic
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indomethacin, early antibiotics (started
in the first 72 hours and given for $5
days), respiratory support in the NICU
(supplemental oxygen, CPAP or assisted
ventilation, surfactant, inhaled nitric
oxide), postnatal corticosteroids, and
any humanmilk feeding. Center rates of
specific interventions (ie, percentage of
mothers or infants receiving an in-
tervention) were calculated by aggre-
gating individual patient data for
eligible infants over the period of the




and to evaluate 2 major sources of vari-
ation that might explain differences in
mortality among centers: patient risk
factors and center intervention rates.
The assessment of center intervention
rates by the presence or absence of
patient-level risk factors in a hierarchical
model was conducted by using 4 models
(Table 1). The derivation and underlying
assumptions of themodels are described
in Appendix 1.
Each model yields an estimated pa-
rameter that measures the average
centermortality (in log odds terms) and
themortality variance,anestimateof the
magnitude of variation or dispersion in
center mortality. An estimatedmortality
variance significantly greater than zero
indicates variation in mortality among
centers that is unlikely to have occurred
by chance alone. A decrease in the
variance estimates from models with,
to those without, center intervention
rates indicates the degree to which
these interventions explain the center
difference in mortality. By using prin-
cipal components analysis, all center
intervention rates were assigned ap-
propriate weights and combined into
a single center intervention score for
inclusion in the final models. Principal
components analysis allowed this to be
accomplished despite the collinearity
(ie, high correlation between indepen-
dent variables) among intervention
rates. A technical description of the
principal components analysis is pro-
vided in Appendix 2 and Appendix Table.
Theclinical implicationsof thesemodels,
ie, theirability toexplain centervariation
in mortality rate, are described below.
Model 1: Intercept Only
This baseline reference model includes
center mortality data and is used to as-
sess the level of and variation in overall
center mortality but does not include
patient risk factors or the intervention
score.
Model 2: Center Intervention Rates
This model extends Model 1 by adding
the center intervention score as a pre-
dictor of mortality to assess the extent
to which variation of center mortality
can be explained by center intervention
rates. Compared with Model 1, the de-
crease in the estimated mortality var-
iance provides a measure of overall
center mortality that can be explained
by intervention rates, without correct-
ing for patient population.
Model 3: Patient-Level Risk Factors
This model includes only infant and
maternal characteristics. It is used to
assess the magnitude of center varia-
tion in mortality while controlling for
infant and maternal characteristics.
Models 3 and 4 can be compared di-
rectly only with each other and not with
Model 1 or 2.
Model 4: Patient Risk Factors and
Center Intervention Rates
Thismodel extendsModel 3 byadding the
center intervention score as a predictor
of center mortality and includes cova-
riates of the infant and maternal char-
acteristics. This model is used to assess
the effect of the intervention rates on
center mortality after controlling for
patient-level risk factors. A decrease in
the mortality variance provides a mea-
sure of the center variation in mortality
explained by center intervention rates
after controlling for patient risk factors.
These models were derived for all
infants and for the subgroups with GAs
,25 weeks and $25 weeks. All mod-
eling analyses were performed by us-
ing the Xtmelogit command in Stata 12
(StataCorp, College Station, TX).
RESULTS
Wide ranges in intervention rates and
mortality were observed among NRN
centers for infants of all GAs as well as
for those with GAs,25 weeks and$25
weeks (Table 2, Fig 1). The ranges of the
intervention rates for infants with GA
,25 weeks were typically wider than
those for infants with GA $25 weeks.
Our major estimation results from the
multilevel models are summarized in
the following paragraphs (Table 3).
Infants of All GAs: Early Mortality
Model 2 indicates the intervention
score had a significant associationwith
center mortality (odds ratio [OR]: 0.79;
95% confidence interval [CI]: 0.74–0.84)
and reduced the center mortality var-
iance from 0.38 to 0.07. After control-
ling for patient risk factors in Models
3 and 4, the association of the in-
tervention score remained significant
(OR: 0.76; 95% CI: 0.67–0.86) and the
mortality variance was reduced by
from 0.64 to 0.27.
Infants of All GAs: In-Hospital
Mortality
Before controlling for individual risk
factors, the intervention score signifi-
cantly reduced the odds of the overall
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center in-hospital mortality (OR: 0.87;
95% CI: 0.83–0.90) and reduced its vari-
ance from 0.16 to 0.03. After controlling
for patient characteristics, the effect of
the intervention score also remained
significant (OR: 0.84; 95% CI: 0.77–0.91)
and reduced the variance of the center
mortality rate from 0.31 to 0.14.
Infants With GA ,25 Weeks: Early
Mortality
The intervention scorewas significantly
related to mortality (OR: 0.76; 95% CI:
0.72–0.79) and accounted for all vari-
ation in mortality among centers as
evidenced by the variance estimate of
0 for Model 2. After accounting for pa-
tient risk factors, the intervention
score was still significant (OR: 0.67;
95% CI: 0.61–0.74) and reduced the
mortality variance from 1.08 to 0.08.
Infants With GA ,25 Weeks:
In-Hospital Mortality
Before correcting for patient charac-
teristics, the intervention score was
significantly related tooddsofmortality
(OR: 0.83; 95% CI: 0.78–0.88) and re-
duced the mortality variance from 0.35
to 0.05. After controlling for individual
risk factors, the intervention score
remained significant (OR: 0.79; 95% CI:
0.71–0.87) and reduced the mortality
variance from 0.62 to 0.20 among cen-
ters.
Infants With GA ‡25 Weeks: Early
Mortality
The associationof the interventionscore
with early mortality was significant for
infants with GA $25 weeks but had
a wider CI than that among all infants or
the ,25-week subgroup (OR: 0.84; 95%
CI: 0.73–0.96). Including the intervention
score reduced the center mortality
variance from 0.21 to 0.11. After con-
trolling for patient risk factors, the as-
sociation of the intervention score
became borderline significant (OR: 0.86;
95% CI: 0.73–1.01) and reduced the
variance of the center mortality rate
from 0.25 to 0.17.
Infants With GA ‡25 Weeks:
In-Hospital Mortality
The association of the intervention
score was not statistically significant
either before or after accounting for
patient risk factors.
The mortality variance estimates from
all models, in all subgroups of each
outcome, after accounting for patient
risk factors were significantly greater
thanzero. Thus, center variation inearly
and in-hospital mortality exists even
after controlling for intervention rates
and patient risk factors.
DISCUSSION
Our study yields a number of interesting
points for consideration. First, it reveals
that in the NRN, there was significant
variation among centers in ELBW mor-
tality. This result was true for both early
and in-hospital mortality for each GA
subset; it is shown in the observed center
death rates and also by the significant
center mortality variance estimates from
Model 1, which did not include center
interventions or patient risk factors, for
each outcomeand subgroup. Second, our
modeling results cast doubt on the
commonly held concept that variation in
outcomes is due largely to differences in
patient population. The center mortality
variance estimates after correcting for
patient risk factors (Model 3) were still
significant for all outcomes and sub-
groups. Finally, center intervention rates
predicted mortality outcomes and re-
duced differences in the outcomes
among the centers. In deriving the in-
tervention scores, interventions not gen-
erally given in the first 12 hours of life
were excluded for the early mortality
outcome. As indicated by the weighting
factors used in the principal components
analysis (Appendix 2), the intervention
scores were primarily composed of the
averages of the center intervention rates
of NICU admission, respiratory support,
supplemental oxygen, surfactant, and,
for infants of,25 weeks’ GA, antenatal
TABLE 2 Medians and Ranges of Center Intervention Rates and Outcomes: 2006–2009







Median Range Median Range Median Range
Intervention
Antenatal corticosteroids 82 35–93 58 21–81 92 47–99
Vaginal vertex delivery 30 22–41 46 31–61 21 16–26
Cesarean delivery 63 45–76 36 10–63 77 68–83
Tracheal intubation 63 41–82 63 24–94 62 37–88
CPAP 29 4–53 9 0–31 39 6–65
NICU admission 86 74–98 65 45–95 99 95–100
Epinephrine 4 1–12 5 0–14 3 1–11
Respiratory support excluding
high-frequency ventilation
80 61–91 54 23–87 95 83–98
Supplemental oxygen 82 61–95 61 26–89 95 87–98
High-frequency ventilation 38 23–76 44 20–84 33 15-–79
Surfactant 70 50–88 61 25–92 77 65–91
Nitric oxide 5 1–22 6 0–44 6 1–20
Postnatal corticosteroids 10 1–29 11 0–50 8 1–23
Prophylactic indomethacin 12 0–80 13 0–75 11 0–94
Early antibiotics 39 23–92 37 16–84 41 22–94
Human milk feeding 64 50–95 41 13–81 81 59–98
Outcome
Early mortality (#12 hours) 18 5–36 42 13–73 3 1–11
In-hospital mortality 34 11–53 63 28–90 16 7–26
The range in the number of infants per center (n) is shown for each GA category.
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corticosteroids, cesarean delivery, and
tracheal intubation. The intervention
scores showed significantly positive
association with both early and in-
hospital mortality in the all-GA pop-
ulation and in the ,25-week GA sub-
group, but they showed only a trend
toward significance in the$25-week GA
subgroup. In addition, the center mor-
tality variance was greatly reduced
when the intervention score was in-
cluded in themodels. These intervention
scores reduced the mortality variance
estimates substantially for both early
and in-hospital mortality for the all-GA
group, and in the ,25-week GA sub-
group the reductionswere even greater.
This finding was true even after cor-
rection for patient risk factors. There-
fore, a substantial number of additional
infants would be predicted to survive
both past 12 hours and until discharge
should the utilization of the examined
interventions be increased for infants at
the earliest gestational ages (,25
weeks). One potential explanation for
the finding that increased intervention
is especially beneficial for infants with
GA ,25 weeks concerns the wider
range of the centers’ use of supportive
therapies in the intrapartum period and
the first hours of life. In particular, there
was large practice variation among
centers in the use of antenatal cortico-
steroids, cesarean delivery, respiratory
support, and NICU admission for these
most premature infants. Our derived in-
tervention score more effectively repre-
sents the specific intervention therapies
examined among infants with GA ,25
weeks than among infants with GA$25
weeks. More research is needed to
identify and determine other factors as-
sociated with mortality among infants
with GA$25 weeks.
This study’s strengths include the use of
high-quality data from the centers of the
NRN collected by trained research staff
applying standardized methods. The use
of prospectively collected data has
presumably limited the probability of
selection bias and misclassification of
covariates and outcomes. The use of the
hierarchical modeling method allowed
us to separate the effects of patient- and
center-level variables and to assess the
impacts of center-level variables both on
mortality and on its variability among
centers. Limitations of the study include
the relatively small number of centers.
Also, capturing all variability in care is
unlikely given the limited number of
elements in the NRN database, even after
correcting for patient-level differences.
Thus, some interventions or approaches
not available in the NRN database may
affect center mortality rates. This ob-
servational study reveals an association
between interventions and survival, but
intervention trials are required to dem-
onstrate a true causal link between
specific interventions and patient sur-
vival. Finally, our study was not able to
examine variability in physician-level
FIGURE 1
Mortality rates by center. A, Results for infants of all GAs (22 [0/7] through 28 [6/7] weeks). B, Results for
infantswithGAof22[0/7] through24[6/7]weeks.C,Results for infantswithGAof25[0/7] through28[6/7]
weeks. Closed circles represent in-hospital mortality and open circles early (#12 hours) mortality. The
size of the circles represents the number of infants treated at a given center over the study period. The
centers are ordered by in-hospital mortality for each graph individually, which means that a center
may not have the same number in each panel.
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care within centers or the quality with
which interventions were implemented,
which are additional possible contrib-
utors to variation in outcome.
Our results show that even though ag-
gressive interventionwithmore infants
would increase survival, the use of the
interventionswe studied does not fully
explain the center variation in mor-
tality, which implies that there are
unaccounted-forvariables thataffect the
center differences inmortality. Previous
studies have postulated what these
factorsmay be. Horbar et al12 found that
patient volume and the presence of a
residency program were not predictive
of outcomes. Rogowski et al13 found that
the percentage of Medicaid beneficia-
ries, type of hospital ownership, and
presence of a teaching hospital were
not significant predictors of outcomes.
These investigators also found that very
low volume centers had worse out-
comes and that the outcome was re-
lated to the level of NICU. These findings
do not explain the variation in mortality
among NRN centers, which are all high-
volume, high-level centers.
Our results suggest that decisions of
whether to resuscitate very preterm
infants affect mortality and are detect-
able at the center level. This observation
raises ethical issues. However, creating
clear policies on the appropriateness of
resuscitating ELBW infants is extremely
difficult,15,16 and a thorough examina-
tion of this topic is beyond the scope of
this study. This report simply highlights
that increased survival is possible, and
the authors believe that decision mak-
ers (parents and physicians) should be
aware of this fact. More aggressive in-
tervention of these neonates would in-
crease their likelihood of survival. The
current study does not address the im-
pact of more aggressive intervention on
the likelihood of “intact” survival, ie, sur-
vival without major neurodevelopmental
impairment, but this association has
been shown in this network.17 More active
intervention of extremely preterm infants
may benefit not only these infants but also
more mature infants; centers in which
intensive care is more frequently pro-
vided to extremely preterm infants have
been shown to have better outcomes, too,
for preterm infants of later gestation.18
Neonatal carehasbeenadvancedby the
development and testing of beneficial
therapies.19 It is important to note that
the magnitude of the center effect on
ELBW mortality is larger than the inter-
vention effects of even the most potent
therapies, such as antenatal cortico-
steroids and surfactant replacement
therapy. This fact underscores the im-
portance of stratification by center in all
multicenter clinical trials in neonato-
logy. The findings of our study support a
role for comprehensive, well-designed,
quality-improvement trials focusing on
the care of very early GA infants.
CONCLUSIONS
There are large differences among
centers in the mortality rate of ex-
tremely preterm infants. Patient char-
acteristics do not adequately account
for this variability. Center use of certain
interventions predicts survival for the
lowest GA infants, but it explains little of
the observed variability in in-hospital
mortality for infants born at $25
weeks. Some as-yet-unmeasured char-
acteristics of the centers account for
the remainder of the observed vari-
ability. The variation in mortality among
centers may be reduced through stan-
dardization of care for very early GA
infants. However, other center differ-
ences may explain the residual differ-
ences in mortality.
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All GAs: in-hospital mortality
Variance in mortality 0.16 (0.07–0.37) 0.03 (0.01–0.09) 0.31 (0.14–0.67) 0.14 (0.06–0.32)
OR of intervention 0.87 (0.83–0.90) 0.84 (0.77–0.92)
GA ,25 weeks: early mortality
Variance in mortality 0.50 (0.23–1.10) 0a 1.08 (0.49–2.40) 0.08 (0.02–0.38)
OR of intervention 0.76 (0.72–0.79) 0.67 (0.61–0.74)
GA,25 weeks: in-hospital mortality
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GA $25 weeks: early mortality
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Variance in center mortality (log odds of mortality) and ORs for intervention scores of center intervention rates are shown
(95% CI in parentheses).
a Not statistically significant.
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APPENDIX 1: SPECIFICATIONS OF
MULTILEVEL HIERARCHICAL
MODELS
Denote the outcome variable by an
indicator yij, such that patient i in
center j will die (yij = 1) or survive
(yij = 0). Let aj be a random variable
and uj be a normally distributed
random-error term with a mean of
0 and an SD of s for center j. Let PCJ be
the principal components score from
the center intervention rates with
coefficients g1 and x1ij … x9ij repre-
senting the 9 patient and maternal
characteristics with corresponding
coefficients (b1 … b0). The 4 model
forms used for the probability of




ðP ðyijÞ ¼ 1Þ



















P ðyij ¼ 1Þ
P ðyij ¼ 0Þ

¼ aj þ b1x1ij þ
⋯þ b9x9ij
Center-Level Model




ðP ðyÞij ¼ 1Þ





aj ¼ g0 þ g1PCj þ mj
On the basis of the above models, the
average center mortality rate and its
range within 2 SDs (presented in Tables
2 and 3) can be computed as
eg0
1þ eg0
and the range as
eg0j 6 2s
1þ eg0j 6 2s
APPENDIX 2: COMPOSITION OF
FIRST PRINCIPAL COMPONENTS OF
CENTER INTERVENTION RATES
Principal components analysis is a
method to reduce thenumberof variables
under consideration. We have included as
many as 15 types of interventions in this
study. It isunrealistic to includeall of these
interventions simultaneously in the mul-
tilevel models, but we can try to derive an
index from these intervention rates and
use it as a predictor. The principal com-
ponents generated from the intervention
ratesaresuch indices in the formof linear
combinationsof theinterventionratesand
can best represent the variation of these
intervention rates among centers. A brief
description of the method follows.
Let X represent a matrix in which each
column contains the intervention rates
for a center and b represent a stan-
dardized vector of the weighting factors
in the linear combination of the in-
tervention rates such that b9b = 1. For
simplicity of notation, the intervention
rates are deducted by their means so
that they have a mean of 0. Then, linear
combinations of the intervention rates
can be represented for all centers as
b9X.
A variance estimate of linear combina-




Note that XX9/(n 2 1) is a variance es-
timate of the intervention rates and of-
ten denoted byS. Principal components
analysis produces a set of uncorrelated
linear combinations whose variances,
added together, are identical to that in
S. Usually, they are ordered by their
variances, and the proportion of vari-
ance to total variance indicates their
relative importance. The first principal
component that has the maximum vari-
ance is often of particular interest Those
principal components with a small vari-
ance may be ignored.
The proportion of variance and the
weighting factorb for the first principal
component of the intervention rates for
predicting early mortality and in-
hospital mortality are shown below. It
can be seen that the proportion of
variance is higher for the intervention
rates for early mortality and much
higher among infants with GA ,25
weeks. Also, these principal compo-
nents are essentially an average of all
center rates except for CPAP and epi-
nephrine. The weighting factors for the
center rates are nearly equal, but those
for CPAP and epinephrine are close to
zero. Similarly, the principal components
score for in-hospital mortality is an aver-
age of all center rates except for
CPAP, epinephrine, and prophylactic in-
domethacin.
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APPENDIX TABLE Proportion of Variance andWeighting Factors (b) for the First Principal Component of the Intervention Rates
for Predicting Early Mortality and In-Hospital Mortality
Early Mortality In-Hospital Mortality
All Infants GA ,25 Weeks GA $25 Weeks All Infants GA ,25 Weeks GA $25 Weeks
Variance accounted for by first principal component, % 53.2 69.8 31.2 44.7 60.5 25.1
Principal component (weighting factors)
Antenatal corticosteroids 0.34 0.33 20.01 0.31 0.30 0.07
Cesarean delivery 0.36 0.33 20.24 0.33 0.30 20.09
Tracheal intubation 0.29 0.35 0.40 0.26 0.32 0.35
CPAP 20.05 0.10 20.16 0.00 0.12 0.01
NICU admission 0.38 0.34 0.32 0.33 0.30 0.16
Epinephrine 0.00 0.09 20.30 0.02 0.09 20.09
Respiratory support excluding high-frequency ventilation 0.34 0.31 0.34 0.30 0.28 0.12
Supplemental oxygen 0.39 0.35 0.44 0.36 0.31 0.36
High-frequency ventilation 0.23 0.28 0.13 0.24 0.26 0.35
Surfactant 0.38 0.36 0.46 0.34 0.32 0.42
Early antibiotics 0.25 0.32 0.15 0.27 0.30 0.34
Postnatal corticosteroids NA NA NA 0.23 0.20 0.30
Prophylactic indomethacin NA NA NA 20.02 0.08 20.21
Nitric oxide NA NA NA 0.15 0.17 0.30
Human milk feeding NA NA NA 0.28 0.31 0.22
NA, not applicable.
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